NanoRepro AG
NanoRepro AG NN6.DE Peers
See (NN6.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NN6.DE | €1.37 | +3.79% | 17.7M | -5.48 | -€0.25 | N/A |
| TN8.DE | €355.55 | -1.11% | 134.2B | 23.72 | €14.99 | +0.38% |
| DAP.DE | €167.98 | +0.57% | 120.2B | 37.08 | €4.53 | +0.57% |
| ILU.DE | €73.36 | +1.51% | 11.6B | -13.71 | -€5.35 | N/A |
| QIA.DE | €39.15 | +1.33% | 8.5B | 103.01 | €0.38 | +3.20% |
| SYAB.DE | €11.06 | -0.18% | 2.4B | 27.65 | €0.40 | N/A |
| ECX.DE | €0.70 | -11.17% | 612.6K | -0.04 | -€19.55 | N/A |
| 4NC.F | €0.00 | N/A | 0 | 0.07 | €0.05 | N/A |
Stock Comparison
NN6.DE vs TN8.DE Comparison
NN6.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NN6.DE stands at 17.7M. In comparison, TN8.DE has a market cap of 134.2B. Regarding current trading prices, NN6.DE is priced at €1.37, while TN8.DE trades at €355.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NN6.DE currently has a P/E ratio of -5.48, whereas TN8.DE's P/E ratio is 23.72. In terms of profitability, NN6.DE's ROE is -0.08%, compared to TN8.DE's ROE of +0.13%. Regarding short-term risk, NN6.DE is more volatile compared to TN8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for NN6.DE.